Page last updated: 2024-10-26

dipyridamole and Esophageal and Gastric Varices

dipyridamole has been researched along with Esophageal and Gastric Varices in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Esophageal and Gastric Varices: Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brady, L1
Magilavy, D1
Black, DD1
Fisher, RS1
Cohen, S1

Other Studies

2 other studies available for dipyridamole and Esophageal and Gastric Varices

ArticleYear
Portal vein thrombosis associated with antiphospholipid antibodies in a child.
    Journal of pediatric gastroenterology and nutrition, 1996, Volume: 23, Issue:4

    Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Child, Preschool; Dipyridamole; Esophageal a

1996
Disorders of the lower esophageal sphincter.
    Annual review of medicine, 1975, Volume: 26

    Topics: Acetylcholine; Chagas Disease; Dipyridamole; Esophageal Achalasia; Esophageal and Gastric Varices; E

1975